COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …
challenge in this century. Two years after its emergence, the rapid development and …
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
M Lipsitch, F Krammer, G Regev-Yochay… - Nature Reviews …, 2022 - nature.com
Breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) in fully vaccinated individuals are receiving intense scrutiny because of their importance …
2) in fully vaccinated individuals are receiving intense scrutiny because of their importance …
Waning immunity after the BNT162b2 vaccine in Israel
Abstract Background In December 2020, Israel began a mass vaccination campaign against
coronavirus disease 2019 (Covid-19) by administering the BNT162b2 vaccine, which led to …
coronavirus disease 2019 (Covid-19) by administering the BNT162b2 vaccine, which led to …
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar
Background Waning of vaccine protection against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern …
coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern …
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
D Goldblatt, G Alter, S Crotty… - Immunological reviews, 2022 - Wiley Online Library
Antibodies against epitopes in S1 give the most accurate CoP against infection by the SARS‐
CoV‐2 coronavirus. Measurement of those antibodies by neutralization or binding assays …
CoV‐2 coronavirus. Measurement of those antibodies by neutralization or binding assays …
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
T Fiolet, Y Kherabi, CJ MacDonald, J Ghosn… - Clinical Microbiology …, 2022 - Elsevier
Background Vaccines are critical cost-effective tools to control the coronavirus disease 2019
(COVID-19) pandemic. However, the emergence of variants of the severe acute respiratory …
(COVID-19) pandemic. However, the emergence of variants of the severe acute respiratory …
Protection of BNT162b2 vaccine booster against Covid-19 in Israel
Abstract Background On July 30, 2021, the administration of a third (booster) dose of the
BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons …
BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons …
The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review
I Mohammed, A Nauman, P Paul… - Human vaccines & …, 2022 - Taylor & Francis
With the relatively rapid development of the COVID-19 pandemic, vaccine development has
become crucial for limiting disease transmission. The accelerated growth in the approved …
become crucial for limiting disease transmission. The accelerated growth in the approved …
Effectiveness of Covid-19 vaccines over a 9-month period in North Carolina
Background The duration of protection afforded by coronavirus disease 2019 (Covid-19)
vaccines in the United States is unclear. Whether the increase in postvaccination infections …
vaccines in the United States is unclear. Whether the increase in postvaccination infections …
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
effectiveness against infection (VE-I) and death (VE-D) by vaccine type in 780,225 veterans …
effectiveness against infection (VE-I) and death (VE-D) by vaccine type in 780,225 veterans …